Cary Street Partners Investment Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
8,104
+1,120
+16% +$131K 0.21% 112
2026
Q1
$840K Buy
6,984
+957
+16% +$110K 0.21% 110
2025
Q4
$634K Buy
6,027
+1,044
+21% +$98K 0.17% 134
2025
Q3
$418K Buy
4,983
+245
+5% +$20.2K 0.17% 129
2025
Q2
$375K Sell
4,738
-974
-17% -$77.4K 0.18% 139
2025
Q1
$513K Sell
5,712
-412
-7% -$38.5K 0.3% 85
2024
Q4
$609K Sell
6,124
-178,841
-97% -$18.4M 0.4% 57
2024
Q3
$21M Buy
184,965
+5,347
+3% +$635K 0.77% 28
2024
Q2
$22.2M Buy
179,618
+150
+0.1% +$19.3K 0.9% 18
2024
Q1
$23.7M Buy
179,468
+145
+0.1% +$17.9K 1% 12
2023
Q4
$19.5M Buy
179,323
+175
+0.1% +$18.2K 0.93% 16
2023
Q3
$18.4M Buy
179,148
+62,621
+54% +$6.75M 0.99% 14
2023
Q2
$13.4M Buy
116,527
+3,180
+3% +$361K 0.86% 22
2023
Q1
$12.1M Sell
113,347
-1,663
-1% -$180K 0.87% 23
2022
Q4
$12.8M Sell
115,010
-2,059
-2% -$210K 0.94% 20
2022
Q3
$10.1M Buy
117,069
+9,098
+8% +$812K 0.83% 34
2022
Q2
$9.84M Buy
107,971
+68,618
+174% +$6.08M 0.83% 30
2022
Q1
$3.25M Sell
39,353
-134
-0.3% -$10.6K 0.89% 28
2021
Q4
$3.03M Buy
39,487
+4,132
+12% +$329K 0.84% 30
2021
Q3
$2.66M Sell
35,355
-1,097
-3% -$83.4K 0.87% 32
2021
Q2
$2.83M Buy
36,452
+11,385
+45% +$847K 0.92% 30
2021
Q1
$1.84M Sell
25,067
-48,450
-66% -$3.57M 0.76% 32
2020
Q4
$5.74M Sell
73,517
-43,728
-37% -$3.34M 1.11% 16
2020
Q3
$9.28M Buy
+117,245
New +$9.18M 1.96% 5
2020
Q1
Sell
-2,319
Closed -$201K 104
2019
Q4
$201K Buy
+2,319
New +$190K 0.22% 117

Other funds holding MRK

Cary Street Partners Investment Advisory's MRK Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Merck (MRK) stake by 16% in Q2 2026, buying an estimated $131K and bringing the position to 8,104 shares worth $1.04M. The position accounts for 0.21% of the portfolio, ranked #112.

Cary Street Partners Investment Advisory first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $23.7M in Q1 2024. 2,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cary Street Partners Investment Advisory held 8,104 shares of Merck worth $1.04M as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 1,120 Merck shares in Q2 2026, an estimated $131K.
  • Merck made up 0.21% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #112 holding.
  • Cary Street Partners Investment Advisory first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • Cary Street Partners Investment Advisory's Merck position peaked at $23.7M in Q1 2024.
  • 2,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.